Skip to main content
. 2011 Jun 28;105(2):246–254. doi: 10.1038/bjc.2011.197

Figure 3.

Figure 3

Distribution of K-Ras, B-Raf and PIK3CA mutations according to Dukes’ and TNM stage. The presence of mutations in K-Ras, B-Raf, and PIK3CA was determined by pyrosequencing analysis as described in the ‘Materials and methods’ section. Tumours were categorised according to (A) Dukes’ and (B) TNM staging, and further sub-divided by the presence of mutations in K-Ras, B-Raf, and PIK3CA. *P=0.03, **P=0.00002.